Catalyst Wire Dossier Catalyst Wire Dossier

Golexanolone

golexanolone · Umecrine Cognition AB
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Golexanolone, covering 2026-03-09 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction [Phase 1, Phase 2]

See pricing